Burke Bioventures provides strategic advice and scientific direction for biotechnology, pharmaceutical, and drug delivery companies, and interim R&D management of venture-backed start-ups. In addition we provide technical due diligence in support of venture investment, licensing, and M&A.
Burke Bioventures helps clients stay on top of developments important to their businesses, and provides expert appraisal of biopharmaceutical technologies and technology-based assets for companies considering partnerships, acquisitions, or outsourcing services.
The potential upside of many new technologies can generate enthusiasm which may obscure inevitable challenges in implementation. Critical evaluation is key, both for fair valuation and for ultimately positioning opportunities for successful product development. History and deep domain expertise can serve as valuable guides to anticipating key challenges and to identifying which new technologies are most likely to be successful. A critical evaluation can also help ensure alignment between the probability of success and the risk tolerance level of the buyer.